GSA Capital Partners LLP Boosts Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

GSA Capital Partners LLP increased its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 61.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,736 shares of the biotechnology company’s stock after buying an additional 659 shares during the period. GSA Capital Partners LLP’s holdings in Axon Enterprise were worth $694,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. Blue Trust Inc. increased its position in shares of Axon Enterprise by 987.5% in the 2nd quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock valued at $27,000 after purchasing an additional 79 shares during the last quarter. Quent Capital LLC increased its holdings in Axon Enterprise by 1,875.0% in the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after buying an additional 75 shares during the last quarter. Asset Dedication LLC purchased a new position in Axon Enterprise in the second quarter valued at $47,000. Friedenthal Financial purchased a new stake in Axon Enterprise during the 3rd quarter worth about $51,000. Finally, Cullen Frost Bankers Inc. purchased a new stake in Axon Enterprise during the 2nd quarter worth about $59,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several brokerages have recently weighed in on AXON. JMP Securities raised their target price on Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research report on Thursday, October 31st. Barclays raised their price objective on shares of Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. Northland Securities increased their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. The Goldman Sachs Group lifted their price target on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Finally, Robert W. Baird upped their price objective on shares of Axon Enterprise from $440.00 to $460.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. Two research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $427.83.

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $599.35 on Monday. The company has a market cap of $45.70 billion, a PE ratio of 154.87, a P/E/G ratio of 15.05 and a beta of 0.94. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. Axon Enterprise, Inc. has a 1-year low of $220.78 and a 1-year high of $624.84. The stock has a fifty day moving average price of $438.79 and a 200 day moving average price of $357.90.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 70,000 shares of the firm’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $362.21, for a total value of $25,354,700.00. Following the completion of the sale, the chief executive officer now owns 2,945,366 shares of the company’s stock, valued at approximately $1,066,841,018.86. This trade represents a 2.32 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $373.03, for a total transaction of $167,863.50. Following the transaction, the director now owns 7,379 shares in the company, valued at $2,752,588.37. The trade was a 5.75 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 411,006 shares of company stock worth $161,360,618 over the last ninety days. 6.10% of the stock is currently owned by company insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.